Recommended supplementation for both peptides includes: Multivitamin: To cover baseline micronutrient gaps from reduced food intake Vitamin D3: 2,000-4,000 IU daily, as weight loss releases stored vitamin D from fat tissue in unpredictable patterns Magnesium glycinate: 200-400mg daily, supports muscle function and helps with constipation Omega-3 fatty acids: 1,000-2,000mg EPA/DHA daily for anti-inflammatory support B12/methylcobalamin: Especially important if using formulations without added B12 Tirzepatide formulations with B12 and tirzepatide glycine B12 compounds address the B12 need directly
Research from peptide stability studies shows that lyophilized tirzepatide stored at -20 degrees Celsius retains greater than 98% potency for over 24 months
This makes it a dual-action GIP and GLP-1 medication - the first of its kind approved for weight management
Glucose and insulin levels in the tail vein blood were determined by GlucoCard DIA meter and insulin ELISA kit (Morinaga)
Given promise as well as challenges, more research is needed on telehealth and digital interventions for adherence to GLP-1 therapy, long-term weight management, and individual behaviors, health outcomes, quality of life, and satisfaction
The clinical trials used fixed doses (1, 4, 8, and 12 mg) rather than weight-based dosing, which means the same 12 mg dose was given to a 170-pound woman and a 300-pound man
